Iopamidol Production Cost Reports

The report provides a detailed analysis essential for establishing an Iopamidol production plant. It encompasses all critical aspects necessary for Iopamidol production, including the cost of Iopamidol production, Iopamidol plant cost, Iopamidol production costs, and the overall Iopamidol production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Iopamidol production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Iopamidol is a non-ionic contrast agent used primarily in medical imaging procedures. It is commonly used in medical imaging, particularly in X-ray and CT scans, to help visualise blood vessels, organs, and tissues. It functions by blocking X-rays as they pass through the body, thereby allowing blood vessels, organs, and other non-bony tissues to be clearly visualised during radiographic examinations.

It is also utilised in diagnostic procedures, such as angiography, venography, and myelography, to enhance the contrast of images and provide clearer views for accurate diagnoses. Moreover, Iopamidol is also used in urography to evaluate the urinary system and in coronary angiography for heart-related studies. It is also used in various radiological examinations to identify abnormalities in the cardiovascular system, brain, and spine. The compound is administered intravenously or intra-arterially, depending on the type of imaging procedure.

The demand for Iopamidol is primarily driven by its application as a contrast agent in modern medicine for its ability to improve the quality of diagnostic imaging, which significantly boosts its market growth. Its application for various diagnostic imaging procedures, including angiography throughout the cardiovascular system, cerebral and peripheral arteriography, coronary arteriography, and excretory urography, also boosts its demand in the medical sector. Its demand in patients with compromised renal function for various imaging procedures due to its low toxicity and excellent imaging capabilities also promotes its market expansion.

Its application in procedures such as brain scans, heart imaging, and examining the abdomen or pelvis also contributes to its demand in the healthcare and medical diagnostic sectors. Its demand as a contrast agent in interventional radiology, where it facilitates precise analysis for minimally invasive procedures, also fuels its market expansion. Furthermore, advancements in contrast media formulation, reliable supplier networks, sustainable production practices, and efficient distribution systems play an important role in shaping global industrial Iopamidol procurement. In addition, its procurement is also influenced by factors such as the availability and cost of raw materials, strict regulatory requirements, and adherence to quality and safety standards.

Raw Material for Iopamidol Production

According to the Iopamidol production plant project report, the major raw materials for Iopamidol production include 5-Nitroisophthalic Acid, Thionyl Chloride, L-2-acetoxypropionyl chloride, and 2-amino-1,3-propanediol.

Production Process of Iopamidol

The extensive Iopamidol production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of iopamidol begins with the reduction of 5-nitroisophthalic acid to form the corresponding amino diacid. Then, this intermediate is iodinated to form 5-amino-2,4,6-triiodoisophthalic acid, with the amino group activating the aromatic nucleus for iodination. The iodinated compound is treated with thionyl chloride to produce the dichloride, which is then subjected to N-acylation with L-2-acetoxypropionyl chloride. The resulting diacid chloride is amidated with 2-amino-1,3-propanediol (serinol), and the ester group is hydrolysed using aqueous sodium hydroxide to give Iopamidol as the final product.

Iopamidol is a nonionic, low-osmolar iodinated radiocontrast agent that appears as a white crystalline powder that is highly water-soluble. The molecular formula of the compound is C17H22I3N3O8, and its molar mass is 777.09 g/mol. The compound shows excellent aqueous solubility due to its symmetric triiodobenzene ring structure with highly hydrophilic side chains, which makes it suitable for intravenous and intrathecal administration. The compound decomposes at its melting point, which is above 300 °C, and its boiling point is around 740.14 degree Celsius. It is recommended that patients maintain adequate hydration before and after receiving the contrast agent, and healthcare providers should monitor kidney function. It may cause headache, nausea, vomiting, and pain at the injection site. Other serious adverse reactions may include allergic-type reactions, renal toxicity, particularly in patients with pre-existing renal dysfunction, dehydration, seizures following intrathecal administration, and severe cutaneous reactions. Extended use should be carefully evaluated in patients with thyroid disorders, as the compound may affect thyroid function tests for up to 16 days after administration.